Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment

Psychopharmacology (Berl). 1992;106(4):479-83. doi: 10.1007/BF02244818.

Abstract

The effects of administration of antipsychotic drugs (1-32 days, twice per day) on the rat brain mRNA levels of dopamine D1, D2 and D3 receptors has been assessed by a novel procedure utilising solution hybridisation with oligonucleotides. Saline and sulpiride (10 mg/kg/injection) had no effect on D1, D2 and D3 receptor mRNA levels. Haloperidol (1.5 mg/kg/injection) elicited increases in D1, D2 and D3 receptor mRNA levels of 100%, 100% and 300% respectively, after 32 days and loxapine (2 mg/kg/injection) elicited increases of 450%, 150% and 550%, respectively. These results indicate that the up-regulation of dopamine receptors may be associated with the occurrence of tardive dyskinesia but not the clinical mode of action of antipsychotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents / pharmacology*
  • Blotting, Northern
  • Brain Chemistry / drug effects*
  • Haloperidol / pharmacology
  • Loxapine / pharmacology
  • Male
  • Oligonucleotides
  • RNA, Messenger / biosynthesis*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / biosynthesis*
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Sulpiride / pharmacology

Substances

  • Antipsychotic Agents
  • Drd3 protein, rat
  • Oligonucleotides
  • RNA, Messenger
  • Receptors, Dopamine
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Sulpiride
  • Haloperidol
  • Loxapine